Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $222,225 | 139 | 93.7% |
| Food and Beverage | $13,987 | 337 | 5.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 2 | 0.2% |
| Entertainment | $389.34 | 10 | 0.2% |
| Education | $156.74 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $114,703 | 61 | $0 (2022) |
| CSL Plasma Inc. | $104,740 | 72 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $4,598 | 46 | $0 (2024) |
| Allergan, Inc. | $2,993 | 91 | $0 (2022) |
| Lumenis BE inc | $1,381 | 1 | $0 (2024) |
| Optos, Inc. | $1,160 | 22 | $0 (2021) |
| ABBVIE INC. | $1,077 | 34 | $0 (2024) |
| Shire North American Group Inc | $734.02 | 36 | $0 (2019) |
| Ivantis, Inc | $712.62 | 12 | $0 (2021) |
| Ocular Therapeutix, Inc. | $700.29 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $57,301 | 65 | CSL Plasma Inc. ($55,197) |
| 2023 | $50,949 | 67 | CSL Plasma Inc. ($49,544) |
| 2022 | $59,806 | 60 | CSL Behring ($58,549) |
| 2021 | $20,261 | 53 | CSL Behring ($18,835) |
| 2020 | $38,837 | 45 | CSL Behring ($37,319) |
| 2019 | $5,080 | 74 | Johnson & Johnson Surgical Vision, Inc. ($2,698) |
| 2018 | $2,908 | 78 | Johnson & Johnson Surgical Vision, Inc. ($811.90) |
| 2017 | $2,065 | 53 | Johnson & Johnson Surgical Vision, Inc. ($660.93) |
All Payment Transactions
495 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/06/2024 | Lumenis BE inc | M22 (Device) | Food and Beverage | Cash or cash equivalent | $1,380.98 | General |
| Category: Dermathology | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: EYE CARE | ||||||
| 11/13/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $65.07 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 11/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $41.13 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/28/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,533.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 3,408 | 3,934 | $907,192 | $224,659 |
| 2022 | 15 | 3,183 | 3,844 | $1.2M | $262,801 |
| 2021 | 22 | 3,619 | 4,546 | $2.0M | $438,166 |
| 2020 | 18 | 3,218 | 4,066 | $1.8M | $382,444 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 654 | 679 | $169,945 | $52,946 | 31.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 487 | 763 | $135,730 | $44,104 | 32.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 442 | 442 | $130,050 | $38,992 | 30.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 117 | 154 | $133,241 | $35,420 | 26.6% |
| 92250 | Photography of the retina | Office | 2023 | 1,060 | 1,091 | $213,170 | $26,009 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $31,535 | $9,187 | 29.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 266 | 403 | $55,511 | $8,429 | 15.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 84 | 86 | $14,220 | $3,541 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $6,860 | $2,550 | 37.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 57 | 58 | $8,010 | $1,448 | 18.1% |
| 92134 | Imaging of retina | Office | 2023 | 27 | 27 | $4,005 | $764.78 | 19.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 91 | 99 | $2,685 | $696.14 | 25.9% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 11 | 20 | $2,230 | $573.36 | 25.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 115 | 151 | $386,107 | $58,385 | 15.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 617 | 640 | $118,400 | $51,054 | 43.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 507 | 741 | $96,330 | $42,280 | 43.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 398 | 398 | $89,550 | $36,320 | 40.6% |
| 92250 | Photography of the retina | Office | 2022 | 950 | 1,003 | $250,750 | $24,297 | 9.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 67 | 84 | $77,616 | $19,085 | 24.6% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 22 | 28 | $84,000 | $15,085 | 18.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 223 | 500 | $63,388 | $8,826 | 13.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 72 | 72 | $12,600 | $3,079 | 24.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 48 | 51 | $9,945 | $1,362 | 13.7% |
| 92134 | Imaging of retina | Office | 2022 | 31 | 32 | $6,240 | $973.30 | 15.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 72 | 78 | $1,950 | $573.13 | 29.4% |
About Dr. Jay Bradley, M.D
Dr. Jay Bradley, M.D is a Cornea and External Diseases Specialist healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912042763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Bradley, M.D has received a total of $237,208 in payments from pharmaceutical and medical device companies, with $57,301 received in 2024. These payments were reported across 495 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($222,225).
As a Medicare-enrolled provider, Bradley has provided services to 13,428 Medicare beneficiaries, totaling 16,390 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Cornea and External Diseases Specialist
- Other Specialties Ophthalmology
- Location Lubbock, TX
- Active Since 02/20/2007
- Last Updated 06/27/2019
- Taxonomy Code 207WX0120X
- Entity Type Individual
- NPI Number 1912042763
Products in Payments
- Tecnis Symfony IOL (Device) $2,368
- BOTOX (Biological) $1,552
- M22 (Device) $1,381
- Tecnis 1-piece IOL (Device) $958.83
- Monaco (Device) $757.60
- DEXTENZA (Drug) $700.29
- XIIDRA (Drug) $673.95
- Tecnis Multifocal Family of 1-piece IOLS (Device) $661.22
- BOTOX COSMETIC (Biological) $611.95
- Hydrus (Device) $562.74
- LUMIGAN (Drug) $459.92
- Rhopressa (Drug) $381.16
- California (Device) $296.32
- TYRVAYA (Drug) $253.27
- HYDRUS Microstent (Device) $239.20
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $234.84
- VYZULTA (Drug) $220.14
- VERITAS Vision System (Device) $150.37
- Hydrus Microstent (Device) $149.88
- LOTEMAX SM (Drug) $146.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.